Technology is key to recruiting and retaining clinical trial participants
Voluntary role
Related Posts
‘Top-down’ treatment strategy dramatically improves outcomes for Crohn’s patients
Approximately 80% of patients taking Remicade from diagnosis had symptoms controlled Researchers from the University […]
PhaSER Biomedical receives $2.3m drug discovery grant from the Gates Foundation
Every year, tuberculosis, malaria and HIV cause over five million deaths worldwide PhaSER Biomedical has […]
Agomab announces positive phase 2a interim results for AGMB-129
FSCD therapy meets all endpoints in interim analysis Agomab Therapeutics NV (Agomab) has announced positive […]